The Pivot patch pump in use [Image from Modular Medical]Modular Medical (Nasdaq:MODD) announced that it entered into a new ...

Home or hospital insulin pumps are safe and improve glucose control in pediatric, adolescent, and young adult patients with type 1 diabetes hospitalized for noncritical illness. "Safety is not ...

Many children with type 1 diabetes benefit from technology—including insulin pumps and continuous glucose monitoring (CGM) devices—to help manage their blood sugar level, which is key to staying ...

Using home insulin pumps when hospitalized was relatively safe compared with hospital-managed pumps and insulin injections among more than 2700 children admitted to a single hospital center. Findings ...

Modular Medical Inc. MODD, on Tuesday, announced that the first patients have completed onboarding and training and are now ...

Tandem Diabetes Care, Insulet and Dexcom all presented data over the weekend at the American Diabetes Association’s Scientific Sessions.

Most of the 38 million people living with diabetes in the U.S. use daily injections or insulin pumps to keep glucose at safe levels — but new research suggests that a third option could be just as ...

First Patients Began Device Training and Insulin Delivery Today, Marking Transition to a Commercial Company Pivot is the First Insulin Pump Designed to Address the Large, Underserved Population of ...

Insulin pumps are the most advanced insulin delivery technology available today for people with type 1 and type 2 diabetes. An insulin pump replaces injections with a syringe or insulin pen, using an ...

Please provide your email address to receive an email when new articles are posted on . Providers should screen for disordered eating behaviors among adolescents with type 1 diabetes using an insulin ...

Researchers at the University of Washington School of Medicine recently published a first-of-its-kind study looking at an oft-overlooked problem facing people with diabetes who use insulin pump ...

The U.S. Food and Drug Administration has issued a Class I "most serious type of recall" for an iOS app used in conjunction with an insulin pump. The "correction" as referred to by the FDA on ...